I am an economist–statistician specialising in trial-based and quasi-experimental evaluation, predictive modelling, and cost–benefit analysis. I work with linked administrative and clinical datasets to answer policy questions across health, labour, housing, and criminal justice, and I build reproducible pipelines in R/Stata/Python/SQL for secure data environments—an approach reinforced through my work as a contributor to the Institute for Replication (I4R).
I am currently a Senior Research Associate at UNSW’s Nura Gili Centre for Indigenous Programs, and an Adjunct Senior Lecturer at the University of Sydney’s NHMRC Clinical Trials Centre. I serve on the Editorial Board of the International Journal of Drug Policy, and I’m a member of the NSW Population & Health Services Research Ethics Committee (PHSREC).
UNSW profile · CV · Research / Teaching statements · Google Scholar · ORCID · ResearchGate · X · LinkedIn
I’m actively looking for HDR/PhD candidates and collaborators. My work spans econometrics, biostatistics, epidemiology, and health economics, and I work closely with applied partners on decision-facing questions. I also do expert witness / independent expert reports for courts and tribunals, which keeps me grounded in what “decision-ready” evidence looks like: clear assumptions, transparent methods, careful interpretation, and outputs that stand up to scrutiny. As a result, I regularly come across concrete, high-impact projects that can be shaped into publishable theses.
If you’re interested, email me at sergei.v.alexeev@gmail.com with a short note about your background and interests, or message me on WhatsApp at +61 457 871 540. You’re also welcome to reach out to my current and past students for candid feedback on my supervision style (e.g., Alexandra Gallagher, Jessica Cornish, and Oscar Ninou).
I help organisations answer high-stakes, decision-facing questions with evidence that is transparent, defensible, and usable. My consulting work combines economics, biostatistics, and health economics to evaluate policies, programs, and technologies — from causal impact evaluation (trial-based and quasi-experimental) to economic evaluation (cost-effectiveness, cost–benefit, budget impact) and clear decision briefs for non-technical audiences.
My background spans corporate finance and project delivery (Russia/France), economics (Canada), and a PhD in economics, and I now apply that toolkit in Australian public health and policy. Practically, that means I scope quickly, agree on the decision, comparators and assumptions up front, build a workable data strategy, and deliver decision-ready outputs (including reproducible code where appropriate). I’m comfortable working in secure data environments (including PLIDA) and maintain current HILDA access, so projects can move from question → analysis → defensible write-up without hand-waving.
I also produce expert witness / independent expert reports for courts and tribunals, which keeps me grounded in what “stands up to scrutiny”: clear logic, transparent methods, careful interpretation, and sensitivity analysis that makes uncertainty explicit. Selected engagements include expert witness work for the Fair Work Commission (AM2024/20; instructed by Piper Alderman) and the Industrial Relations Commission of NSW (2025/187709), advisory input for Deloitte and Rennie Advisory, and cross-agency evaluation work with NSW Justice Health, Corrective Services NSW, and BOCSAR.
If you’d like to discuss a project, email me at with a few lines on the decision you need to make, your timeline, and what data you have (or can access). I’ll reply with a simple scope and options.